Revenue falls short of Applied Genetic Technologies

Fourth quarter revenue for Applied Genetic Technologies Corp. (Nasdaq: AGTC) fell short of expectations sending the stock price plummeting $4.19 to close at $9.00.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.